1. Introduction {#sec0005}
===============

According to WHO 2015, cardiovascular diseases (CVD) causes higher number of deaths worldwide. Statistics had shown that 17.5 million people died from CVD in 2012, representing 31% of all deaths worldwide, from that 7.4 million died due to coronary artery disease. (Retrivedfrom [www.who.int/mediacentre/factsheets/fs317/en/](http://www.who.int/mediacentre/factsheets/fs317/en/){#intr0005}).

The correct treatment for acute coronary syndrome (ACS) should start as soon as possible after onset of the symptoms to decrease the associated morbidity and mortality. Every 30 min of delay leads to increase at 7.5% of relative risk for 1-year mortality. Median times range from 1.5 to 6.0 h form onset of symptoms to arrival at ER. Major obstacleingetting timely treatment is related to the patient's inability to take decision and reluctance to seek treatment.[@bib0005] (Retrieved from [http://repository.usfca.edu/cgi/viewcontent.cgi?article=1074&context=nursing_fac](http://repository.usfca.edu/cgi/viewcontent.cgi?article=1074%26context=nursing_fac){#intr0010}).

A study done by Farshidi et al[@bib0010], to find the factors causing pre hospital delay among acute myocardial infarction (AMI) patients. They included 227 study samples and found that 35.7% of patients arrived within one hour of symptom onset and 7.9% arrived after 24 h and remaining arrived between one and twenty four hours (*doi:10.5812/ircmj.2367*).

Goel et al[@bib0020] conducted a study on 609 patients with AMI out of which 316 (51.6%) sought late medical attention (\>6 h) and 88 (14.5%) sought medical help after 12 h (*doi:10.1016/S0019-4832\[12\]60090-x*).

Hwang et al[@bib0025] did a study on cognitive factors influencing delay in decisions to seek treatment among patients with AMI. The sample included 94 male and 71 female patients who were hospitalized for AMI. The median pre-hospital delay was 12 h. The study found that low education level is one of the factors for delayed decisions. (Retrieved from [http://203.199.194.78:2165/ehost/detail/detail?vid=21&sid=925731d0-0d89-43c5-9443-3fe4d46bee0a%40sessionmgr4003&hid=4204&bdata=JnNpdGU9ZWhvc3QtbGl2ZQ%3d\#AN=104304732&db=ccm](http://203.199.194.78:2165/ehost/detail/detail?vid=21%26sid=925731d0-0d89-43c5-9443-3fe4d46bee0a%40sessionmgr4003%26hid=4204%26bdata=JnNpdGU9ZWhvc3QtbGl2ZQ%3d#AN=104304732%26db=ccm){#intr0015}).

A study conducted by Momeni et al[@bib0035] in Iran to find the factors influencing pre-hospital delay among patients with AMI. They conducted a study on 162 patients with STEMI. Their findings showed that admission in weekend, false interpretation of symptoms and not so serious about the condition were the factors influenced pre-hospital delay. (*doi:10.3760/cma.j.issn.0366-6999.2012.19.008*).

Khan et al[@bib0030] conducted a prospective study from March 2014--February 2016 on 1386 STEMI patients. In that they found 1148 took more than 2 h to reach emergency department and 805 took \> 4 h to reach emergency department. They also concluded that major factor for pre-hospital delay was due to misinterpretation of symptoms (45%) and next to that was transportation related problems (27%). (Retrieved from <https://www.ncbi.nlm.nih.gov/pubmed/28598044#>).

George et al[@bib0015] did a cross sectional study among 96 patients with STEMI. They found that median pre-hospital delay was 4.8 h. The factors contributed to delay were rural residence, poor financial status, symptom misinterpretation and onset at home, using public transportation, less sessions about symptoms. (Retrieved from <http://www.onlinejets.org/text.asp?2017/10/2/64/201580>).

Thus pre-hospital delay remains problematic and mostly associated with the risk of disability and death and lack of research to find out the factors contributing in treatment seeking delay in Indian scenario, it is the focus of this research to explore the factors.

2. Objectives of the study {#sec0010}
==========================

The objectives were to:•Assess the extent of delay for seeking treatment.•Explore the factors contributing to treatment seeking delay.•Compare factors contributing to treatment seeking delay among patients who had timely treatment and those who had delayed treatment.

3. Methodology {#sec0015}
==============

3.1. Research design {#sec0020}
--------------------

This study used retrospective design.

3.2. Variables {#sec0025}
--------------

Focused variables were demographic, clinical, cognitive and social support factors.

3.3. Setting of the study {#sec0030}
-------------------------

The study conducted on hospitalized adults with a confirmed diagnosis of AMI through emergency department at KMCH Coimbatore.

3.4. Population of the study {#sec0035}
----------------------------

The populations included in this study were hospitalized adults with a confirmed diagnosis of AMI at KMCH.

3.5. Sample size {#sec0040}
----------------

The sample size was 93 from which 51 sought treatment before 120 min and 42 sought treatment after 120 min from the onset of symptoms with a confirmed diagnosis of AMI.

3.6. Sampling technique {#sec0045}
-----------------------

Non-probability purposive sampling was adapted to select the samples for the study.

3.7. Criteria for sample selection {#sec0050}
----------------------------------

[Inclusion criteria]{.ul}1.Patient who had a medical diagnosis of AMI that was confirmed by classic electrocardiogram changes (ECG) and/or abnormal cardiac bio-markers such as elevated cardiac enzymes troponin-T and CK-MB;2.Patient who were hemodynamically stable condition confirmed by stable vital signs and being free of chest pain and/or discomfort at the time of the interview;3.Patients who were above 18 years of age, both male and female;4.Patient who were alert and oriented to person, place, time and situation with no history of cognitive impairment.

[Exclusion criteria]{.ul}1.Patients who were critically ill.2.If AMI was a subsequent medical diagnosis and not the initial reason for seeking treatment.3.Patients with previous history of AMI.

3.8. Development and description of tool {#sec0055}
----------------------------------------

It consist of four parts:

PART I : Deals with demographic data.

PART II : ACS Clinical Data Extraction Form.

PART III : Cognitive factors assessment questionnaire.

PART IV : Duke Social support scale.

**PART I: Deals with demographic data**

Demographic factors such as age, gender, marital status, education, type of family, occupation, monthly income were included.

**PART II: ACS clinical data extraction form**

Clinical factors such as history of AMI, presenting symptoms (typical and atypical- not accompanied by chest pain) of AMI, self-reported pain level on arrival, history of co-morbid illness were included.

**PART III: Cognitive factors assessment questionnaire**

It consists of three parts.1.Knowledge regarding AMI,2.Symptom perception and3.Perceived level of seriousness, measured by researcher prepared questionnaire.

A\) [Knowledge regarding AMI]{.ul}

This contains 8 questions with score of maximum 20 marks. Categorization is done as:

Score '0-5' − poor knowledge.

Score '6-10' − average knowledge.

Score '11-15' − good knowledge.

Score '16-20' − very good knowledge.

B\) [Symptom perception]{.ul}.

This contains 5 point scale to explore how similarly the patients perceived symptoms.

1 − Not at all similar

2 − Mildly similar

3 − Moderately similar

4 − Very similar

5 − Extremely similar

C\) Perceived Level of Seriousness. This contains 5 point scale to explore the how seriously patient perceived their symptoms.

1 − Not at all serious

2 − Mildly serious

3 − Moderately serious

4 − Very serious

5 − Extremely serious

**PART IV: Duke Social Support Scale**

DUKE SOCIAL SUPPORT AND STRESS SCALE was prepared by Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA. Duke Social Support Scale is a part of it and works to capture an individual's perceptions of how supportive or stressful his or her relationships with others. This was used to explore the level of social support received by patient at this movement of his life. Both family and non-familial support was explored. Using a 4 point scale ("none", "some", "a lot", "there is no such person") and a yes or no question. The respondent rates his or her family members, non-family members and special supportive person as people who give personal support (12 items). Raw scores allotted as 'none'- '0', 'some'-- '1', 'a lot'-- '2', 'there is no such person'-- '0', 'yes'-- '2', 'no'-- '0'. Total support was derived from the addition of family, non-family and special support scores and dividing by 22. The scores are obtained between 0 and 100. For the purpose of analysis the family, non-family and social support was divide into two categories. '0-50′- inadequate support, '51--100'- adequate support. The Duke's stress scale was not used for this study.

4. Validity {#sec0060}
===========

The validity of the tool was established by submitting the questionnaires to the experts in the field of medical surgical nursing as well as medical experts. Based on their suggestions and recommendation, the main study carried out.

5. Reliability {#sec0065}
==============

Cronbach's Alpha method is used to establish the reliability of the tool. The reliability coefficients of the cognitive factor assessment questionnaire was found to be satisfactory (knowledge questionnaire- α = 0.785, symptom perception scale- α = 0.823 and perceived seriousness scale- α = 0.939). DUKE SOCIAL SUPPORT SCALE is a standardized scale and has a reliability score of 0.76 for family support and 0.67 for non-family support, respectively.

6. Procedure for data collection {#sec0070}
================================

The prior permission was obtained from the ethical committee, concerned authorities and the participants who met the specified inclusion criteria. Data were collected using structured questionnaire by interviewing patients. Data collected by in-person interviews to reduce the possibility of missing data. In order to limit any personal bias during data collection, the investigator used the open and closed-ended questions from the questionnaires to guide the interview. Patients were identified from emergency department as soon as they got admitted in the hospital. Researcher met the patient and explained about the study in detail to make the patient comfortable. After obtaining oral consent, interview procedure was carried out. The clinical data of arrival time to hospital was collected from patients' case sheet to ensure the time delay. Approximately 30 min were taken by each participant for completely answering to all the tools used in the study. The questionnaires allowed for the patient to give a descriptive, narrative account of the events from the time of the onset of symptoms until they reached the emergency department.

7. Data analysis and interpretation {#sec0075}
===================================

This chapter deals with the description of the study subjects, analysis and description of data collected to explore the factors related to treatment seeking delay among adults diagnosed with AMI.

**Section I**: Description of Demographic Variables.

**Section II**: Description of Clinical Data.

**Section III**: Description of Clinical Factor influencing treatment seeking time.

**Section IV:** Distribution of Cognitive Factors influencing treatment seeking time.

**Section V**: Distribution of Social Support Scores.

**Section VI:** Comparison of Clinical and other Factors determining treatment seeking time.

**Section −I: Description of demographic variables**

[Table 1](#tbl0005){ref-type="table"} depicts the distribution of subjects within two groups according to the demographical variables. In both the groups majority were above 50 years of age, male, married. More number of subjects who sought delayed treatment were illiterate. No subjects were in age group of 20--30 years, in divorced group and in extended family group, respectively.Table 1Distribution of subjects according to demographic variables.Table 1SL.NoDemographic VariablesTimely Group (\<120 min) (N = 51)Delayed Group (\>120 min) (N = 42)FrequencyPercentage (%)FrequencyPercentage (%)1Age in Yearsa. 31--4061237b. 41--5010201229c. \>5035692764  2Gendera. Male49963276b. Female241024  3Marital Statusa. Married49964095b. Unmarried1200c. Widow/Widower1225  4Educationa. Illiterate23452252b. Primary\
Education10201126c. Higher Secondary\
education612410d. Degree1223512  5Occupationa. Working Full Time25492150b. Working Part Time714512c. Retired or unemployed15291433d. Disabled, not able to work4825  6Incomea. Less than Rs.10,00013251024b. Rs.11,000--*R*s.20,00013251740c. Rs.21,000--*R*s.30,0001631717d. Above Rs.Rs.30,000919819  7Type of Familya. Nuclear36712764b. Joint15291536

**Section −II: Description of clinical data**

[Table 2](#tbl0010){ref-type="table"} depicts the distribution of subjects within two groups according to the clinical data. In both timely and delayed treatment seeking groups, majority of subjects had no co-morbid illness and had experienced 1 to 2 typical symptoms. Out of 51 subjects who sought timely treatment, one subject (2%) had experienced completely atypical symptoms like sweating and fainting.Table 2Distribution of subjects according to Clinical Data.Table 2SL. NO.Clinical dataTimely Group (\<120 min) (N = 51)Delayed Group (\>120 min) (N = 42)FrequencyPercentage (%)FrequencyPercentage (%)1Co-morbid Illnessa. HTN1325717b. DM1020512c. HTN & DM1020614d. Nil18352457  2Symptomsa. 1--2 Typical symptoms31612662b. All the Typical Symptoms (3 and above)19371638c. Completely Atypical Symptoms (not accompanied by chest pain)1200

[Table 3](#tbl0015){ref-type="table"} shows the distribution of subjects who sought timely treatment.Table 3Distribution of subjects who sought treatment from onset of symptoms to arrival at ER in less than 120 min.Table 3SL.No.Clinical dataTimely Group (N = 51)FrequencyPercentage (%)1Time duration in minutesa. 0--603569b. 61--1201631

[Table 4](#tbl0020){ref-type="table"} shows the extent of time delay of the subjects who sought treatment after 120 min from the onset of the symptoms. There were two subjects (5%) who sought treatment after two days.Table 4Distribution of subjects who sought delayed treatment after 120 min from the onset of symptoms.Table 4SL.No.Clinical dataDelayed Group (N = 42)FrequencyPercentage (%)1Time duration in minutes (extent of delay)a. 2--6 h2150b. 6--12 h717c. 12--18 h49d. 18--24 h512e. 24--48 h37f. Above 48 h25

**Section −III: Description of clinical factor influencing treatment seeking time**

[Table 5](#tbl0025){ref-type="table"} depicts two things, pain score and presence of chest pain. Majority of subjects who sought timely treatment as well as delayed treatment had experienced moderate pain level. Eight (16%) of subjects and 10 (24%) of subjects who sought timely and delayed treatment, respectively experienced absolutely no pain. Subjects with reduced pain were higher in delayed group. As the pain score increased, the numbers of subjects were also increased in timely treatment seeking group. Majority of subjects in both groups had experienced chest pain with other symptoms.Table 5Distribution of subjects according to Pain Score and Chest Pain.Table 5SL.No.Clinical FactorsTimely Group (\<120 min) (N = 51)Delayed Group (\>120 min) (N = 42)FrequencyPercentage (%)FrequencyPercentage (%)1Pain Scorea. 08161024b. 1--2 (mild)8161331c. 3--6 (moderate)29561945d. 7--10 (severe)61200  2Chest Paina. Pain other than chest region816819b. Chest Pain with other Symptoms42823174c. Only Chest Pain1237

**Section −IV: Distribution of cognitive factors influencing treatment seeking time**

[Table 6](#tbl0030){ref-type="table"} depicts distribution of subjects according to cognitive factors that has three components namely knowledge score, symptom perception and perceived level of seriousness. This shows that most of the subjects who sought delayed treatment (55%) had poor knowledge and most of the subjects who sought timely treatment (33%) had very good knowledge about AMI. Symptom perception describes that subjects who did not perceived their symptoms were highest (79%) in delayed treatment seeking group. Highest number of subjects (82%) in timely treatment seeking group had perceived extremely serious about their condition ([Fig. 1](#fig0005){ref-type="fig"}, [Fig. 2](#fig0010){ref-type="fig"}).Table 6Distribution of subjects according to Knowledge Score, Symptom Perception and Perceived Seriousness.Table 6SL. No.Cognitive FactorsTimely Group (\<120 min) (N = 51)Delayed Group (\>120 min) (N = 42)FrequencyPercentage (%)FrequencyPercentage (%)1Knowledge about AMIa. Poor \[0-5\]5102355b. Average \[6--10\]1529921c. Good \[11--15\]1428512d. Very Good \[16--20\]1733512  2Symptom Perceptiona. 1 (Not at all Similar)6123379b. 2 (Mildly Similar)24614c. 3 (Moderately Similar)142725d. 4 (Very Similar)142700e. 5 (Extremely Similar)153012  3Perceived Level of Seriousnessa. 1 (Not at all serious)122150b. 2 (Mildly serious)001229c. 3 (Moderately serious)00614d. 4 (Very serious)81625e. 5 (Extremely serious)428212Fig. 1Distribution of subjects according to their Knowledge Scores ([Table 6](#tbl0030){ref-type="table"}).Fig. 1Fig. 2Distribution of subjects according to their Perceived Seriousness ([Table 6](#tbl0030){ref-type="table"}).Fig. 2

**Section −V: Distribution of social support scores**

[Table 7](#tbl0035){ref-type="table"} depicts distribution of subjects according to family support scores, non-family support scores and social support scores.Table 7Distribution of subjects according to Duke Social Support and Stress Scale (DUSOCS) Family support score, DUSOCS Non-family support score and DUSOCS Social Support score calculated by using DUKE SOCIAL SUPPORT SCALE.Table 7SL. No.DUSOCS Social SupportTimely Group (\<120 min) (N = 51)Delayed Group (\>120 min) (N = 42)FrequencyPercentage (%)FrequencyPercentage (%)1DUSOCS Family Support scorea. 0--50 (Inadequate)21412867b. 51--100 (Adequate)30591433  2DUSOCS Non-Family Support Scorea. 0 (No support)19373276b. 1--50 (Inadequate)22431024c. 51--100 (Adequate)102000  3DUSOCS Social Support Scorea. 0--50 (Inadequate)28553993b. 51--100 (Adequate)234537

Family support scores shows that out of 51 subjects who sought timely treatment, 41% got inadequate and 59% got adequate family support respectively. Out of 42 subjects who sought delayed treatment, 67% got inadequate and 33% got adequate family support. Non-family support score shows that most subjects (76%) sought delayed treatment did not receive non-family support at all. Also 19 out of 51 subjects who sought timely treatment did not received any non-family support. Social support scores shows that most of the subjects (93%) who delayed in seeking treatment had received inadequate social support ([Fig. 3](#fig0015){ref-type="fig"}, [Fig. 4](#fig0020){ref-type="fig"}, [Fig. 5](#fig0025){ref-type="fig"}).Fig. 3Distribution of subjects according to DUSOCS Family Support score ([Table 7](#tbl0035){ref-type="table"}).Fig. 3Fig. 4Distribution of subjects according to DUSOCS Non-Family Support score ([Table 7](#tbl0035){ref-type="table"}).Fig. 4Fig. 5Distribution of subjects according to DUSOCS Social Support score ([Table 7](#tbl0035){ref-type="table"}).Fig. 5

**Section −VI: Compare the clinical and other factors determining treatment seeking time**

[Table 8](#tbl0040){ref-type="table"} shows that the mean pain score of subjects who sought delayed treatment is less than those who sought timely treatment, thus reduced pain level in the subjects with AMI is a factor for delay in seeking treatment. The significant value (by using Mann-Whitney *U* test) 0.037 for pain score, is significant at p \< 0.05. Thus there is a significant difference between pain scores of subjects who sought timely treatment (less than 120 min) and delayed treatment (more than 120 min) ([Fig. 6](#fig0030){ref-type="fig"}).Table 8Comparison of pain scores of subjects between delayed and timely treatment seeking group.Table 8SL. No.Pain ScoreNMeanS.DSig. Value1\>120 min (Delay Group)422.26191.725840.037\*2\<120 min (Timely Group)513.37252.46545[^1]Fig. 6Comparison of mean pain scores of subjects who sought delayed treatment and timely treatment ([Table 8](#tbl0040){ref-type="table"}).Fig. 6

[Table 9](#tbl0045){ref-type="table"} shows the comparison of knowledge scores of subjects between subjects who sought delayed and timely treatment respectively. The mean knowledge score is more in subjects who sought timely treatment, thus low knowledge about AMI in the patients with AMI is one of the factor for delay in seeking treatment. The significant value (by using Mann-Whitney *U* test) 0.000 for knowledge scores, is significant at p \< 0.05. Thus there is significant difference between knowledge scores of subjects who sought timely treatment (less than 120 min) and delayed treatment (more than 120 min) ([Fig. 7](#fig0035){ref-type="fig"}).Table 9Comparison of knowledge scores of between subjects who sought delayed and timely treatment respectively.Table 9SL. No.Knowledge ScoresNMeanS.DSig. Value1\>120 min (Delay Group)425.73815.780790.000\*2\<120 min (Timely Group)5112.27455.79337[^2]Fig. 7Comparison of mean knowledge scores between subjects who sought delayed treatment and timely treatment ([Table 9](#tbl0045){ref-type="table"}).Fig. 7

[Table 10](#tbl0050){ref-type="table"} shows the comparison of symptom perception of subjects between delayed and timely treatment seeking groups respectively. The mean symptom perception was more in timely treatment seeking group (\<120 min group), thus reduced symptom perception in the patients with AMI is a factor for delay in seeking treatment. The significant value (by using Mann-Whitney *U* test) 0.000 for symptom perception, is significant at p \< 0.05. Thus there is significant difference between symptom perceptions of subjects who sought timely treatment (less than 120 min) and delayed treatment (more than 120 min) ([Fig. 8](#fig0040){ref-type="fig"}).Table 10Comparison of symptom perception of subjects.Table 10SL. No.Symptom PerceptionNMeanS.DSig. Value1\>120 min (Delay Group)421.30950.780500.000\*2\<120 min (Timely Group)513.66671.30639[^3]Fig. 8Comparison of mean symptom perception between delayed treatment and timely treatment group ([Table 10](#tbl0050){ref-type="table"}).Fig. 8

[Table 11](#tbl0055){ref-type="table"} shows the comparison of perceived seriousnessof subjects between delayed and timely treatment seeking group respectively. The mean perceived seriousness was more in timely treatment seeking group, thus less perceived seriousness in the patients with AMI is a factor for delay in seeking treatment. The significant value (by using Mann-Whitney *U* test) 0.000 for perceived seriousness, is significant at p \< 0.05. Thus there is significant difference between perceived seriousness of subjects between delayed and timely treatment seeking group, respectively ([Fig. 9](#fig0045){ref-type="fig"}).Table 11Comparison of perceived seriousness of subjects between delayed and timely treatment seeking groups.Table 11SL. No.Perceived SeriousnessNMeanS.DSig. Value1\>120 min (Delay Group)421.83331.010110.000\*2\<120 min (Timely Group)514.76470.65079[^4]Fig. 9Comparison of mean perceived seriousness of subjects belonging todelayed and timely treatment group ([Table 11](#tbl0055){ref-type="table"}).Fig. 9

[Table 12](#tbl0060){ref-type="table"} shows the comparison of DUSOCS family support score of subjects between delayed and timely treatment seeking group, respectively. The mean family support score is more in timely treatment group, thus low family support in the patients with AMI is a factor for delay in seeking treatment. The significant value (by using Mann-Whitney *U* test) 0.000 for family support, is significant at p \< 0.05. Thus there is significant difference between DUSOCS family support score of subjects between delayed and timely treatment seeking group, respectively ([Fig. 10](#fig0050){ref-type="fig"}).Table 12Comparison of DUSOCS family support score of subjects betweendelayed and timely treatment seeking group respectively.Table 12SL.No.DUSOCS Family Support ScoreNMeanS.DSig. Value1\>120 min (Delay Group)4242.682921.076250.000\*2\<120 min (Timely Group)5157.449216.35976[^5]Fig. 10Comparison of mean DUSOCS family support score betweensubjects who sought delayed and timely treatment ([Table 12](#tbl0060){ref-type="table"}).Fig. 10

[Table 13](#tbl0065){ref-type="table"} shows the comparison of DUSOCS non-family support score of subjects between delayed and timely treatment seeking group respectively. The mean non-family support score is more in timely treatment group, thus low non-family support in the patients with AMI is a factor for delay in seeking treatment. The significant value (by using Mann-Whitney *U* test) 0.000 for non-family support, is significant at p \< 0.05. Thus there is significant difference between DUSOCS non-family support score of subjects between delayed and timely treatment seeking group, respectively ([Fig. 11](#fig0055){ref-type="fig"}).Table 13Comparison of DUSOCS non-family support score of subjects betweendelayed and timely treatment seeking group respectively.Table 13SL.No.DUSOCS Non-Family Support ScoresNMeanS.DSig. Value1\>120 min (Delay Group)424.761911.095610.000\*2\<120 min (Timely Group)5124.902023.94766[^6]Fig. 11Comparison of mean DUSOCS non-family support score between subjects who soughtdelayed and timely treatment ([Table 13](#tbl0065){ref-type="table"}).Fig. 11

[Table 14](#tbl0070){ref-type="table"} shows the comparison of DUSOCS social support score of subjects between delayed and timely treatment seeking group, respectively. The mean social support score is more in timely treatment group, thus low social support in the patients with AMI is a factor for delay in seeking treatment. The significant value (by using Mann-Whitney *U* test) 0.000 for total social support, is significant at p \< 0.05. Thus there is significant difference between DUSOCS social support score of subjects between delayed and timely treatment seeking group, respectively ([Fig. 12](#fig0060){ref-type="fig"}).Table 14Comparison of DUSOCS social support score of subjects betweendelayed and timely treatment seeking group respectively.Table 14SL.No.DUSOCS Social Support ScoresNMeanS.DSig. Value1\>120 min (Delay Group)4229.213813.772360.000\*2\<120 min (Timely Group)5148.300215.64416[^7]Fig. 12Comparison of mean DUSOCS social support score betweendelayed and timely treatment group ([Table 14](#tbl0070){ref-type="table"}).Fig. 12

**Major findings**•Out of 93 study subjects 81 were male and 12 were female. 40% of male subjects and 83.33% of female subjects sought delayed treatment. This shows that there is increased risk of delayed treatment seeking behavior in females ([Table 1](#tbl0005){ref-type="table"}).•Education and occupation doesn't seem to have influence on treatment seeking behavior as almost equal numbers of subjects were found in both the groups ([Table 1](#tbl0005){ref-type="table"}).•Out of 93 study subjects 51 (55%) not at all received non-family support. This proves how much our society has become self centered ([Table 7](#tbl0035){ref-type="table"}, [Fig. 4](#fig0020){ref-type="fig"}).•The mean pain score of subjects who sought delayed treatment (2.2619) is less than those who sought timely treatment (3.3725). The computed significant value (by using Mann-Whitney *U* test) 0.037, is significant at p \< 0.05. Thus there is a significant difference between pain scores of subjects who sought timely treatment (less than 120 min) and delayed treatment (more than 120 min) ([Table 8](#tbl0040){ref-type="table"}, [Fig. 6](#fig0030){ref-type="fig"}).•The mean knowledge score is more in subjects who sought timely treatment (12.2745) than those who sought delayed treatment (5.7381). The computed significant value (by using Mann-Whitney *U* test) 0.000, is significant at p \< 0.05. Thus there is significant difference between knowledge scores of subjects who sought timely treatment (less than 120 min) and delayed treatment (more than 120 min) ([Table 9](#tbl0045){ref-type="table"}, [Fig. 7](#fig0035){ref-type="fig"}).•The mean symptom perception was more in timely treatment seeking group (3.6667) than in delayed treatment seeking group (1.3095). The computed significant value (by using Mann-Whitney *U* test) 0.000, is significant at p \< 0.05. Thus there is significant difference between symptom perceptions of subjects who sought timely treatment (less than 120 min) and delayed treatment (more than 120 min) ([Table 10](#tbl0050){ref-type="table"}, [Fig. 8](#fig0040){ref-type="fig"}).•The mean perceived seriousness was more in timely treatment seeking group (4.7647) than in delayed treatment seeking group (1.8333). The computed significant value (by using Mann-Whitney *U* test) 0.000, is significant at p \< 0.05. Thus there is significant difference between perceived seriousnessof subjects who sought timely treatment (less than 120 min) and delayed treatment (more than 120 min) ([Table 11](#tbl0055){ref-type="table"}, [Fig. 9](#fig0045){ref-type="fig"}).•The mean family support score is more in timely treatment group (57.4492) than in delayed treatment seeking group (42.6829). The computed significant value (by using Mann-Whitney *U* test) 0.000, is significant at p \< 0.05. Thus there is significant difference between DUSOCS family support score of subjects who sought timely treatment (less than 120 min) and delayed treatment (more than 120 min) ([Table 12](#tbl0060){ref-type="table"}, [Fig. 10](#fig0050){ref-type="fig"}).•The mean non-family support score is more in timely treatment group (24.902) than in delayed treatment seeking group (4.7619). The computed significant value (by using Mann-Whitney *U* test) 0.000, is significant at p \< 0.05. Thus there is significant difference between DUSOCS non-family support score of subjects who sought timely treatment (less than 120 min) and delayed treatment (more than 120 min) ([Table 13](#tbl0065){ref-type="table"}, [Fig. 11](#fig0055){ref-type="fig"}).•The mean social support score is more in timely treatment group (48.3002) than in delayed treatment seeking group (29.2138). The computed significant value (by using Mann-Whitney *U* test) 0.000, is significant at p \< 0.05. Thus there is significant difference between DUSOCS social support score of subjects who sought timely treatment (less than 120 min) and delayed treatment (more than 120 min) ([Table 14](#tbl0070){ref-type="table"}, [Fig. 12](#fig0060){ref-type="fig"}).

8. Conclusion {#sec0080}
=============

**The following conclusions are drawn from the study**•This study concludes that the decreased pain level, absence of chest pain and presence of chest pain alone were the factors related to treatment seeking delay among patients with AMI.•This study draws a conclusion that the less knowledge about AMI, reduced symptom perception and perceived seriousness (cognitive factors) respectively were also the factors related to treatment seeking delay among patients with AMI.•This study showed that the inadequate family support, non-family support and social support were also the factors related to treatment seeking delay among patients with AMI.

[^1]: \*Significance p \< 0.05.

[^2]: \*Significance p \< 0.05.

[^3]: \*Significance p \< 0.05.

[^4]: \*Significance p \< 0.05.

[^5]: \*Significance p \< 0.05.

[^6]: \*Significance p \< 0.05.

[^7]: \*Significance p \< 0.05.
